ScholarIQanswers from OpenAlex

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

PaperCitations, authors & open-access status

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis have?

ScholarIQcitation count

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis has 2,884 citations in the OpenAlex counts ScholarIQ stores.

When was Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis published?

ScholarIQyear

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis has 2013 year in the ScholarIQ index.

What is the open-access status of Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis?

ScholarIQoa status

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis has bronze oa status in the ScholarIQ index.

What is the DOI of Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis?

ScholarIQdoi

The DOI for Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis is on the source record.

What is the PMID of Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis?

ScholarIQpmid

The PMID for Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis is on the source record.

What is the OpenAlex record for Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis?

ScholarIQopenalex

The OpenAlex for Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial